210 related articles for article (PubMed ID: 20831527)
1. Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.
Raffa RB; Tallarida RJ
J Clin Pharm Ther; 2010 Jun; 35(3):249-55. PubMed ID: 20831527
[TBL] [Abstract][Full Text] [Related]
2. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.
Raffa RB
J Clin Pharm Ther; 2010 Feb; 35(1):1-9. PubMed ID: 20175809
[TBL] [Abstract][Full Text] [Related]
3. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
Raffa RB; Duong PV; Finney J; Garber DA; Lam LM; Mathew SS; Patel NN; Plaskett KC; Shah M; Jen Weng HF
J Clin Pharm Ther; 2006 Apr; 31(2):129-38. PubMed ID: 16635046
[No Abstract] [Full Text] [Related]
4. Chemotherapy-related visual system toxicity.
Raffa RB
Adv Exp Med Biol; 2010; 678():113-8. PubMed ID: 20738012
[TBL] [Abstract][Full Text] [Related]
5. A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').
Raffa RB
J Clin Pharm Ther; 2011 Jun; 36(3):257-9. PubMed ID: 21545608
[TBL] [Abstract][Full Text] [Related]
6. Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment).
Raffa RB
J Clin Pharm Ther; 2013 Aug; 38(4):265-8. PubMed ID: 23656522
[TBL] [Abstract][Full Text] [Related]
7. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.
Aluise CD; Sultana R; Tangpong J; Vore M; St Clair D; Moscow JA; Butterfield DA
Adv Exp Med Biol; 2010; 678():147-56. PubMed ID: 20738017
[TBL] [Abstract][Full Text] [Related]
8. Clearing the air: a review of our current understanding of "chemo fog".
O'Farrell E; MacKenzie J; Collins B
Curr Oncol Rep; 2013 Jun; 15(3):260-9. PubMed ID: 23483375
[TBL] [Abstract][Full Text] [Related]
9. Patient's perspective.
Raffa RB; Martin KJ
Adv Exp Med Biol; 2010; 678():11-2. PubMed ID: 20738000
[TBL] [Abstract][Full Text] [Related]
10. Chemo fog: cancer chemotherapy-related cognitive impairment. Preface.
Raffa RB; Tallarida RJ
Adv Exp Med Biol; 2010; 678():vii-viii. PubMed ID: 20737998
[No Abstract] [Full Text] [Related]
11. Chemotherapy-induced prospective memory impairment in patients with breast cancer.
Cheng H; Yang Z; Dong B; Chen C; Zhang M; Huang Z; Chen Z; Wang K
Psychooncology; 2013 Oct; 22(10):2391-5. PubMed ID: 23674402
[TBL] [Abstract][Full Text] [Related]
12. Fighting the fog of "chemo brain." Chemotherapy may keep your cancer at bay but it also may cloud your mind.
Duke Med Health News; 2009 Feb; 15(2):8-9. PubMed ID: 19353815
[No Abstract] [Full Text] [Related]
13. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
Shilling V; Jenkins V; Trapala IS
Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment associated with adjuvant therapy in breast cancer.
Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM
Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy.
Frank JS; Vance DE; Triebel KL; Meneses KM
J Neurosci Nurs; 2015 Dec; 47(6):302-12. PubMed ID: 26447567
[TBL] [Abstract][Full Text] [Related]
16. Imaging as a means of studying chemotherapy-related cognitive impairment.
Raffa RB
Adv Exp Med Biol; 2010; 678():70-6. PubMed ID: 20738008
[TBL] [Abstract][Full Text] [Related]
17. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.
Rugo HS; Ahles T
Semin Oncol; 2003 Dec; 30(6):749-62. PubMed ID: 14663776
[TBL] [Abstract][Full Text] [Related]
18. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
[No Abstract] [Full Text] [Related]
20. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.
de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; van Dam FS; Nederveen AJ; Boven E; Schagen SB
Hum Brain Mapp; 2011 Aug; 32(8):1206-19. PubMed ID: 20669165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
